Metraipolis › archive › dc_548b78049f6e

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer — Europe PMC PMID:42109891

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42109891
DOI
10.34133/bmr.0358
License (as archived)
solo-consultazione
Archived
2026-11-02T16:59:26.533Z
SHA-256 of the archived text
48100afee361cf0ec2436ba0546837429bab0e088f7b6aae68fa8762512a1513
Stable URL of this page
https://metraipolis.com/documento/dc_548b78049f6e

How to cite

Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer — Europe PMC PMID:42109891 — Europe PMC (en), https://europepmc.org/article/MED/42109891 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_548b78049f6e (Metraipolis archive dc_548b78049f6e, sha256 48100afee361cf0ec2436ba0546837429bab0e088f7b6aae68fa8762512a1513)
BibTeX
@misc{dc548b78049f6e,
  title = {Genetically Engineered Cell Membrane-Coated Nanodrug for Targeted Treatment of Thyroid Cancer — Europe PMC PMID:42109891},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42109891},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_548b78049f6e; sha256 48100afee361cf0ec2436ba0546837429bab0e088f7b6aae68fa8762512a1513},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42109891. Agents can read the archived copy with the MCP tool read_document.